Yanyan Jia

Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Single-cell transcriptomic analyses reveal heterogeneity and key subsets associated with survival and response to PD-1 blockade in cervical squamous cell carcinoma.

Single-cell transcriptomic analyses reveal heterogeneity and key subsets associated with survival and response to PD-1 blockade in cervical squamous cell carcinoma.

Journal: Cancer cell international

Published: September 15, 2024

The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress.

The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress.

Journal: Frontiers in pharmacology

Published: June 03, 2023

miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation.

miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation.

Journal: Cell death & disease

Published: April 23, 2021

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer.

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer.

Journal: Therapeutic advances in medical oncology

Published: June 13, 2020

CircRNA circ_POLA2 Promotes Cervical Squamous Cell Carcinoma Progression via Regulating miR-326/GNB1.

CircRNA circ_POLA2 Promotes Cervical Squamous Cell Carcinoma Progression via Regulating miR-326/GNB1.

Journal: Frontiers in oncology

Published: February 10, 2020

Discovery of a Novel Benzenesulfonamide Analogue That Inhibits Proliferation and Metastasis Against Ovarian Cancer OVCAR-8 Cells.

Discovery of a Novel Benzenesulfonamide Analogue That Inhibits Proliferation and Metastasis Against Ovarian Cancer OVCAR-8 Cells.

Journal: Drug design, development and therapy

Published: July 29, 2019

P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition.

P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition.

Journal: Journal of Cancer

Published: July 14, 2019

PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.

PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.

Journal: Life sciences

Published: May 08, 2019

Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.

Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 12, 2018

Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.

Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.

Journal: Experimental cell research

Published: May 26, 2017

Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.

Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.

Journal: Oncology reports

Published: October 21, 2015

Significance of gastrin-releasing peptide in ovarian cancer ES2 cells.

Significance of gastrin-releasing peptide in ovarian cancer ES2 cells.

Journal: Oncology letters

Published: June 25, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026